G2
Contact
G2
Contact

Research · Healthtech

Healthtech: capital, debt and M&A in Mexico 2026

Andreessen Horowitz, Sierra Ventures and Kfund led rounds of USD 22 to 33 million in 2025 and 2026, strategic buyers acquire home care and hospital management, and digital health is now written into law.

By Jorge González Gasque ( LinkedIn opens in a new window ) · · 6 min read

This note gathers the public transaction activity we use to place a mandate in digital health. Every figure carries its source and date. We include no estimates of our own.

Capital raising

Telepatia raised a USD 33 million Series A led by Andreessen Horowitz in June 2026, after a USD 9 million seed in October 2025; its AI clinical tool supports more than 14 million patients in Brazil, Colombia, Mexico, Chile and Argentina (LatamList, June 2026).

Eden, a Mexican cloud radiology platform, raised a USD 22 million Series A led by Sierra Ventures in October 2025, with Liquid 2 Ventures and Daniel Servitje; it serves more than 2,200 institutions and 13 million studies a year (LatamList, October 2025).

Sofía closed USD 21 million led by Kfund in May 2026, with Kayyak, Index, Kaszek and BID Lab, for a total of USD 46 million since 2018; more than 1,300 companies buy its health plan (Sofía, May 2026). Plenna raised a USD 6 million Series A led by Mazapil in July 2025 for its clinics and women’s health platform (Contxto, July 2025).

USD 253.7 million invested in Latin American healthtechs in 2024, up 37.6% on 2023, across 56 deals, with fewer and larger rounds; Mexico holds 16.2% of the companies (Distrito, February 2025). Mexico Business News describes 2025 as the year healthtech became the country’s second most active vertical, with rounds of up to USD 400 million for companies combining care and financing.

Debt and structured financing

We found no debt lines with a public amount announced by Mexican healthtechs between 2024 and 2026 in sources we could consult. In mandates we see two structures: financing of medical equipment and clinic infrastructure through leasing or secured debt, and, for health plans, regulatory capital that a lender does not replace. Private insurance grows 6.7% a year with premiums above MXN 90 billion and seven of every ten insured under group policies (AMIS, October 2025), which makes insurers the natural counterparty for a digital health plan.

Mergers and acquisitions

Koltin acquired Last Mile Care, home visits, infusions and post-hospital care, in April 2026; terms undisclosed (LatamList, April 2026). Reliv (Ecuador) acquired Hospisoft, a Mexican hospital management platform, in June 2025; terms undisclosed (LatamList, June 2025). Tracxn records four healthcare SaaS acquisitions in the region in 2025 and two in 2026 against none in 2024 (August 2026).

GNP Seguros and Médica Móvil invested USD 7.8 million in Meddi, a platform with more than 58 hospitals and 5,000 specialists, in March 2026 (LatamList, March 2026): the incumbent buys digital distribution instead of building it.

Market context

41.2% of current health expenditure is out of pocket (World Bank, 2023) and 34.2% of the population, 44.5 million people, has no access to health services (INEGI, 2024). 13,950,851 people insured for medical expenses, about 10% of the population (AMIS, 2024). The reform published in the Official Gazette on 15 January 2026 brings digital health into the General Health Law, defines telehealth and the electronic health record and creates technovigilance with electronic verification by COFEPRIS.

G2’s reading for a mandate

The investment committee distinguishes between companies that sell software to providers and companies that carry care or claims risk: it values the first as SaaS, on retention and margin; the second as an insurer or provider, on medical cost and the book of client companies. The 2025 and 2026 rounds show that international capital enters through AI clinical tools and through health plans with corporate clients. In a sale, the 2026 reform turns compliance into an asset: an electronic health record and a teleconsultation that comply with the law are worth more to a hospital group or an insurer than user volume.

Sources